These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14631326)

  • 1. The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?*.
    Ricordeau P; Weill A; Vallier N; Bourrel R; Schwartz D; Guilhot J; Fender P; Allemand H
    Diabetes Metab; 2003 Nov; 29(5):497-504. PubMed ID: 14631326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cost of diabetes in metropolitan France].
    Ricordeau P; Weill A; Vallier N; Bourrel R; Fender P; Allemand H
    Diabetes Metab; 2000 Sep; 26 Suppl 6():25-38. PubMed ID: 11011237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of diabetes in metropolitan France].
    Ricordeau P; Weill A; Vallier N; Bourrel R; Fender P; Allemand H
    Diabetes Metab; 2000 Sep; 26 Suppl 6():11-24. PubMed ID: 11011236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and treatment of diabetes in France: trends between 2000 and 2005.
    Kusnik-Joinville O; Weill A; Salanave B; Ricordeau P; Allemand H
    Diabetes Metab; 2008 Jun; 34(3):266-72. PubMed ID: 18524662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Use of an ambulatory care pharmacy-derived database.
    Pogach LM; Hawley G; Weinstock R; Sawin C; Schiebe H; Cutler F; Zieve F; Bates M; Repke D
    Diabetes Care; 1998 Mar; 21(3):368-73. PubMed ID: 9540017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
    Rathmann W; Haastert B; Icks A; Giani G
    Diabetes Care; 2007 Apr; 30(4):848-53. PubMed ID: 17392545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of health insurance benefits: material and methods].
    Weill A; Ricordeau P; Vallier N; Bourrel R; Fender P; Allemand H
    Diabetes Metab; 2000 Sep; 26 Suppl 6():49-54. PubMed ID: 11011239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct health care costs of diabetic patients in Spain.
    Oliva J; Lobo F; Molina B; Monereo S
    Diabetes Care; 2004 Nov; 27(11):2616-21. PubMed ID: 15504995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
    Köster I; Hauner H; von Ferber L
    Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014.
    Luo J; Avorn J; Kesselheim AS
    JAMA Intern Med; 2015 Oct; 175(10):1681-6. PubMed ID: 26301721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of demographic changes on drug utilization related to diabetes in Aquitaine].
    Taboulet F; Latry P; Fontaine S; Timmerman L
    Cah Sociol Demogr Med; 1999; 39(2-3):253-69. PubMed ID: 10615566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
    Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
    J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and consumption of medication in diabetes mellitus in Madrid (1996-2002)].
    Arrieta FJ; Calvo MJ; Peréz A; Saavedra P; Cordobés FJ; Cabral R; Arrieta JJ; Rovira A
    Rev Clin Esp; 2006 Mar; 206(3):117-21. PubMed ID: 16597376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.